Dion Hubert Zappe

Title: Dion Hubert Zappe: Innovator in Pharmaceutical Compositions

Introduction

Dion Hubert Zappe is a notable inventor based in Andover, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in methods aimed at reducing arterial stiffness. His innovative approach combines therapeutic agents to address critical health issues.

Latest Patents

Dion Zappe holds a patent for "Methods and pharmaceutical compositions for reducing arterial stiffness with a combination of a therapeutic agent blocking the angiotensin receptor and a therapeutic agent inhibiting the NEP enzyme." This invention focuses on administering a combination of sacubitril and valsartan in a 1:1 molar ratio to effectively reduce arterial stiffness in patients exhibiting symptoms such as increased pulse wave velocity (PWV) and increased pulse pressure (PP).

Career Highlights

Dion Zappe is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to contribute to advancements in pharmaceutical research and development. With a focus on innovative solutions, he has played a crucial role in addressing cardiovascular health challenges.

Collaborations

Dion has collaborated with esteemed colleagues such as Sven Erik Godtfredsen and Weinong Guo. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.

Conclusion

Dion Hubert Zappe's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in healthcare. His patent for reducing arterial stiffness showcases his commitment to improving patient outcomes through scientific advancements.